Cargando…
Elevated tissue inhibitor of metalloproteinase-1 along with left atrium hypertrophy predict atrial fibrillation recurrence after catheter ablation
This study aimed to establish a model that predicts atrial fibrillation (AF) recurrence after catheter ablation using clinical risk factors and biomarkers. We used a prospective cohort study, including 230 consecutive persistent AF patients successfully treated with catheter ablation from January 20...
Autores principales: | Sun, Weiping, Li, Haiwei, Wang, Zefeng, Li, Qin, Wen, Haichu, Wu, Yongquan, Du, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663807/ https://www.ncbi.nlm.nih.gov/pubmed/36386356 http://dx.doi.org/10.3389/fcvm.2022.1010443 |
Ejemplares similares
-
Higher serum tissue inhibitor of metalloproteinase-1 predicts atrial fibrillation recurrence after radiofrequency catheter ablation
por: Li, Haiwei, et al.
Publicado: (2022) -
Catheter ablation and thoracoscopic ablation in long persistent atrial fibrillation with large left atrium
por: Park, Chan Soon, et al.
Publicado: (2022) -
Successful Catheter Ablation of Atrial Fibrillation in a Patient With an Abnormal Septum in the Left Atrium
por: Kobayashi, Noriyuki, et al.
Publicado: (2022) -
Sinus node dysfunction after radiofrequency catheter ablation of atrial flutter: A case report
por: Li, Haiwei, et al.
Publicado: (2022) -
Catheter ablation of atrial fibrillation: When turn to the right atrium?
por: Chen, Minglong
Publicado: (2019)